Andrew graduated from the University of York with a First Class BSc in Molecular Cell Biology in 2016.
At University, he conducted research projects into CRISPR knockout of stress-related genes in rice and the effects of LRRK2 and α-synuclein mutations on the visual symptoms of Parkinson’s disease.
Joining another leading patent firm shortly after graduating University, Andrew graduated from Queen Mary University of London with a Postgraduate Certificate in Intellectual Property Law in 2018.
Andrew has significant experience in the drafting and prosecution of patent applications covering inventions across the biotech/life sciences field on behalf of a wide range of clients, from individual inventors to multinational corporations.
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.